AKRO

1 BTC

=

- USD

Akero Therapeutics, Inc. Common Stock logo

Akero Therapeutics, Inc. Common Stock

AKRO🇺🇸
Coming Soon
0.00%

As of May 30, 2026 at 24:05 UTC

Chart

About Akero Therapeutics, Inc. Common Stock

Sector
PHARMACEUTICAL PREPARATIONS
Headquarters
SOUTH SAN FRANCISCO
Employees (FY)
67
Listed
2019-06-20
FIGI
BBG00L9211Y8

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

Market Statistics

Market Capâ‚¿ 61.32K
24h Volume-
24h Change0.00%
7d Change0.00%
1m Change0.00%

Trading Metrics

Trading Volume (BTC)-

How to Buy AKRO

1

Create Your Account

Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.

2

Start Your Trade

From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.

3

Buy AKRO

Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.

New to Tokenized Assets? Learn more in our Help Center.

Latest News

5 articles
GlobeNewswire Inc. favicon
GlobeNewswire Inc.www.globenewswire.com

Law firm investigating potential securities law violations and fiduciary duty breaches for several companies involved in recent merger and acquisition transactions.

Benzinga favicon
Benzingawww.benzinga.com

Law firm Monteverde & Associates is investigating potential merger-related class action lawsuits for several companies, including Anywhere Real Estate, Cartica Acquisition, Berry Corporation, and Akero Therapeutics.

Related:
GlobeNewswire Inc. favicon
GlobeNewswire Inc.www.globenewswire.com

Law firm Halper Sadeh LLC is investigating potential securities law violations and breaches of fiduciary duties for several companies undergoing mergers and acquisitions.

GlobeNewswire Inc. favicon
GlobeNewswire Inc.www.globenewswire.com

Law firm Brodsky & Smith is investigating potential breaches of fiduciary duties by boards of several companies during merger and acquisition processes, focusing on whether shareholders are receiving fair value.

Related:
GlobeNewswire Inc. favicon
GlobeNewswire Inc.www.globenewswire.com

Novo Nordisk reported 12% sales growth in Q3 2025, with strong performance in Obesity and Diabetes care. The company is undergoing a transformation, incurring restructuring costs, and adjusting growth expectations for GLP-1 treatments.

1 BTC

=

- USD

Loading market data...